Understanding how cell division affects brain development in autism

Characterization of midbody remnant mediated cell fate decisions in autism

['FUNDING_R21'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-11039481

This study is looking at how certain brain cells divide and how this might relate to autism, focusing on tiny structures that could help understand how brain development goes awry in some individuals.

Quick facts

Phase['FUNDING_R21']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF WISCONSIN-MADISON (nih funded)
Locations1 site (MADISON, UNITED STATES)
Trial IDNIH-11039481 on ClinicalTrials.gov

What this research studies

This research investigates how the division of neural progenitor cells (NPCs) contributes to brain development and its implications for autism spectrum disorder (ASD). The study focuses on a novel mechanism involving midbody remnants (MBRs), which are large extracellular vesicles that may play a role in transferring genetic information that influences cell fate decisions. By examining the dynamics of MBRs and their associated mRNAs in the developing human cortex, the research aims to uncover the molecular pathways that may lead to neurodevelopmental alterations in individuals with ASD. This collaborative effort seeks to provide insights into the developmental origins of ASD and how various risk factors may impact brain architecture.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with autism spectrum disorder, particularly those under 21 years old.

Not a fit: Patients with autism spectrum disorder who are over 21 years old may not benefit directly from this research.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of the biological mechanisms underlying autism, potentially informing new therapeutic strategies.

How similar studies have performed: While the specific approach of examining midbody remnants in relation to ASD is novel, previous research has shown success in exploring cellular mechanisms related to neurodevelopmental disorders.

Where this research is happening

MADISON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: autism spectral disorder, autism spectrum disorder, Autistic Disorder

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.